As of January 22, 2025, LENZ Therapeutics (LENZ) has a market cap of $0.67 billion USD. According to our data, LENZ Therapeutics is ranked No.5741 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.67 B |
-15.28%
|
Dec 31, 2024 | $0.79 B |
711.22%
|
Dec 29, 2023 | $97.87 M |
-21.08%
|
Dec 30, 2022 | $0.12 B |
-73.29%
|
Dec 31, 2021 | $0.46 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Ocular Therapeutix
OCUL
|
$1.26 B |
-0.000 M
|
USA
|
Kala Pharmaceuticals
KALA
|
$36.53 M |
0.000 M
|
USA
|
Aldeyra Therapeutics
ALDX
|
$0.30 B |
-0.000 M
|
USA
|
EyePoint Pharmaceuticals
EYPT
|
$0.60 B |
-0.000 M
|
USA
|
Ocuphire Pharma
OCUP
|
$31.74 M |
4.753 M
|
USA
|
Alimera Sciences
ALIM
|
$0.30 B |
0.000 M
|
USA
|
Clearside Biomedical
CLSD
|
$72.42 M |
-0.000 M
|
USA
|
Adverum Biotechnologies
ADVM
|
$92.99 M |
-0.000 M
|
USA
|
Apellis Pharmaceuticals
APLS
|
$3.78 B |
-0.000 M
|
USA
|
Kodiak Sciences
KOD
|
$0.42 B |
-0.000 M
|
USA
|
Outlook Therapeutics
OTLK
|
$52.05 M |
-0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Novartis
NVS
|
$196.25 B |
0.003 M
|
Switzerland
|
Market Cap | = | LENZ Stock Price | * | LENZ Shares Outstanding |
= | $24.46 | * | 27.50 M | |
= | $0.67 B |